Human intratumoral therapy: Linking drug properties and tumor transport of drugs in clinical trials
Cancer therapies aim to kill tumor cells directly or engage the immune system to fight
malignancy. Checkpoint inhibitors, oncolytic viruses, cell-based immunotherapies …
malignancy. Checkpoint inhibitors, oncolytic viruses, cell-based immunotherapies …
Human intratumoral therapy: Linking drug properties and tumor transport of drugs in clinical trials.
A Huang, MM Pressnall, R Lu… - Journal of Controlled …, 2020 - europepmc.org
Cancer therapies aim to kill tumor cells directly or engage the immune system to fight
malignancy. Checkpoint inhibitors, oncolytic viruses, cell-based immunotherapies …
malignancy. Checkpoint inhibitors, oncolytic viruses, cell-based immunotherapies …
Human intratumoral therapy: Linking drug properties and tumor transport of drugs in clinical trials
A Huang, MM Pressnall, R Lu… - … : official journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
Cancer therapies aim to kill tumor cells directly or engage the immune system to fight
malignancy. Checkpoint inhibitors, oncolytic viruses, cell-based immunotherapies …
malignancy. Checkpoint inhibitors, oncolytic viruses, cell-based immunotherapies …
[引用][C] Human intratumoral therapy: Linking drug properties and tumor transport of drugs in clinical trials
A Huang, MM Pressnall, R Lu… - Journal of Controlled …, 2020 - cir.nii.ac.jp
Human intratumoral therapy: Linking drug properties and tumor transport of drugs in clinical
trials | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
trials | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …